Toxicology and health risks of hydroquinone in skin lightening formulations

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 7, 2006, Pages 777-780

  Kooyers, T J ^a   Westerhof, W ^a,b  

^a Netherlands Institute for Pigment Disorders   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Health risks; Hydroquinone; Skin lightening; Toxicity

Indexed keywords

1,4 BENZOQUINONE; BENZENE; DNA; HYDROQUINONE; PROTEIN BCL 2; PROTEIN P53;

BIOCHEMISTRY; BONE MARROW; CANCER RISK; CARCINOGENICITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG FORMULATION; DRUG METABOLISM; DRUG RELEASE; DRUG TRANSFORMATION; EVIDENCE BASED MEDICINE; HEALTH HAZARD; HUMAN; LEUKODERMA; MEDICAL LITERATURE; OCHRONOSIS; PRIORITY JOURNAL; PUBLICATION; REVIEW; RISK ASSESSMENT; SKIN CARCINOGENESIS; SKIN COLOR; SKIN DISEASE;

EID: 33746275876     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2005.01218.x     Document Type: Review

References (22)

1. Twenty-fourth directive 2000/6/EG, Publication nr L, 056. European Union, 2000.
2. Menke HE, Gomes PD, Lamur H, Westerhof W. Een tintje lichter. Med Contact 2001; 56(3): 89-91.
3. Snyder R, Hedli CC. An overview of benzene metabolism. Environ Health Perspective 1996; 104(Suppl. 6): 1165-1171.
4. World Health Organization Environmental Health Criteria 157 Hydroquinone 1994.
5. Rao GS. Glutathionyl hydroquinone: A potent pro-oxidant and a possible toxic metabolite of benzene. Toxicology 1996; 106: 49-54.
6. Kooyers TJ, Hydrochinon, het middel erger dan de kwaal? Afstudeerverslag, Open Universiteit, 2002.
7. Gomes PD, Westerhof W. Het gebruik van chemische huidbleekmiddelen onder Ghanese vrouwen in Amsterdam-Zuid-oost. Aanzet tot onderzoek en discussie. Tijdschrift Voor Genderstudies 2001; 4(1): 20-33.
8. Wester RC, Melendres J, Hui X, et al. Human in vivo and in vitro hydroquinone topical bioavailability metabolism and disposition. J Toxicol Environ Health 1998; 54: 301-317.
9. Corley RA, English TS, Hill LA, Fiorica LA, Morgott DA. Development of a physiologically based pharmacokinetic model for hydroquinone. Toxicolol Appl Pharmacol 2000; 165: 163-175.
10. Toxicology and carcinogenesis studies of hydroquinone in F344/N rats and B6C3F1 Mice (gavage Studies), National Toxicology program, NIH Publication 90-2821. Department of Health and Human Services, Washington DC. US, 1989.
11. Shibata MA, Hirose M, Tanaka E, Shirai T. Ino T, Induction of renal cell tumors in rats and mice, and enhancement of hepatocellular tumor development in mice after long-term hydroquinone treatment. Jap J Cancer Res 1991; 82(11): 1211-1219.
12. Lau SS, Monks TJ, Everitt JI, Kleymenova E, Walker CL. Carcinogenicity of a nephrotoxic metabolite of the 'nongenotoxic' carcinogen hydroquinone. Chem Res Toxicol 2001; 14(1): 25-33.
13. -bone-marrow cells. Exp Hematol 2000; 28(2): 169-176.
14. Sze CC, Shi CY, Ong CN. Cytototoxicity and DNA strand breaks induced by benzene and its metabolites in Chinese hamster ovary cells. J Appl Toxicol 1991; 16(3): 259-264.
15. Joseph P, Klein-Szanto AJP, Jaiswal A. Hydroquinones cause specific mutations and lead to cellular transformation and in vivo tumorgenesis. Br J Cancer 1998; 78(3): 312-320.
16. Lee EW, Garner CD. Effects of benzene on DNA strand breaks in vivo versus benzene metabolite-induced DNA strand breaks in vitro in mouse bone marrow cells. Toxicol Appl Pharmacol 1991; 108: 497-508.
17. Hahn WC, Weinberg RA. Modelling the molecular circuitry of cancer. Nature Rev Cancer 2002; 2: 331-341.
18. Kuo M, Shiah S, Wang C, Chuang S. Suppression of apoptosis by Bcl-2 to enhance benzene metabolites induced oxidative DNA damage and mutagenesis: A possible mechanism of carcinogenesis. Mol Pharmacol 1999; 55(5): 894-901.
19. Levin CY, Maibach H. Exogenous ochronosis an update on clinical features causative agents and treatment options. Am J Clin Dermatol 2001; 2(4): 213-217.
20. Chen Y, Shen HM, Shi CY et al. Benzene metabolites, 1, 2, 4-Benzenetriol, induces micronuclei and oxidative DNA damage in human lymphocytes and HL60 cells. Environ Mol Mutagenesis 1993; 21: 339-348.
21. Yin S, Hayes RB, Linet MS et al. An expanded cohort study of cancer among Benzene exposed workers in China Environmental Health. Perspectives 1996; 104: 1339-1341.
22. Briganti S, Camera E, Picardo M. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 2003; 16: 101-111.